NASDAQ:THMO ThermoGenesis (THMO) Stock Price, News & Analysis $0.19 +0.03 (+18.75%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.17▼$0.2050-Day Range$0.13▼$0.6552-Week Range$0.13▼$1.43Volume5,967 shsAverage Volume78,836 shsMarket Capitalization$1.51 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get ThermoGenesis alerts: Email Address ThermoGenesis MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside2,531.6% Upside$5.00 Price TargetShort InterestHealthy1.94% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.73 out of 5 stars 3.5 Analyst's Opinion Consensus RatingThermoGenesis has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageThermoGenesis has received no research coverage in the past 90 days.Read more about ThermoGenesis' stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.94% of the float of ThermoGenesis has been sold short.Short Interest Ratio / Days to CoverThermoGenesis has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ThermoGenesis has recently increased by 94.30%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldThermoGenesis does not currently pay a dividend.Dividend GrowthThermoGenesis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for THMO. Previous Next N/A News and Social Media Coverage Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ThermoGenesis insiders have not sold or bought any company stock.Percentage Held by Insiders78.00% of the stock of ThermoGenesis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 5.78% of the stock of ThermoGenesis is held by institutions.Read more about ThermoGenesis' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of ThermoGenesis is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ThermoGenesis is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about ThermoGenesis' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about About ThermoGenesis Stock (NASDAQ:THMO)ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.Read More THMO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart THMO Stock News HeadlinesJune 12, 2024 | investorplace.comWhy Is ThermoGenesis (THMO) Stock Down 37% Today?May 17, 2024 | investorplace.comTHMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.February 27, 2024 | finance.yahoo.comThermoGenesis Holdings, Inc. (NASDAQ:THMO) Is About To Turn The CornerJanuary 10, 2024 | thestreet.comThermoGenesis Holdings, Inc.December 16, 2023 | benzinga.comThermoGenesis Holdings Stock (NASDAQ:THMO) Dividends: History, Yield and DatesDecember 8, 2023 | finance.yahoo.comShareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time BeingNovember 21, 2023 | benzinga.comThermoGenesis Holdings Recent Insider ActivityJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.November 15, 2023 | finanznachrichten.deThermoGenesis Holdings, Inc.: ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 14, 2023 | finance.yahoo.comThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call TranscriptNovember 13, 2023 | finance.yahoo.comThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 12, 2023 | msn.comThermoGenesis Q3 Earnings PreviewNovember 12, 2023 | markets.businessinsider.comHere's what Wall Street expects from ThermoGenesis's earnings reportNovember 12, 2023 | morningstar.comThermoGenesis Holdings Inc THMONovember 10, 2023 | benzinga.comThermoGenesis Holdings Earnings PreviewNovember 8, 2023 | finance.yahoo.comThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic UpdateOctober 27, 2023 | bizjournals.comThermoGenesis opens shared lab space for immunotherapy medical startupsSee More Headlines Receive THMO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ThermoGenesis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/17/2024Today7/26/2024Next Earnings (Estimated)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Laboratory apparatus & furniture Sub-IndustryMeasuring And Control Equipment Current SymbolNASDAQ:THMO CUSIPN/A CIK811212 Webwww.thermogenesis.com Phone(916) 858-5100Fax916-858-5199Employees40Year Founded1986Price Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+3,025.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($5.14) Trailing P/E RatioN/A Forward P/E Ratio2.00 P/E GrowthN/ANet Income$-17,980,000.00 Net Margins-153.43% Pretax Margin-163.77% Return on Equity-4,838.39% Return on Assets-107.53% Debt Debt-to-Equity RatioN/A Current Ratio0.52 Quick Ratio0.37 Sales & Book Value Annual Sales$9.44 million Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value($0.99) per share Price / Book-0.16Miscellaneous Outstanding Shares7,950,000Free Float1,750,000Market Cap$1.27 million OptionableNot Optionable Beta2.28 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Xiaochun Xu M.B.A. (Age 53)Ph.D., Chairman of the Board & CEO Comp: $520kMr. Jeffery Cauble CPA (Age 51)CFO & Corporate Secretary Comp: $264kMs. Haihong Zhu (Age 58)Chief Operating Officer Comp: $460kKey CompetitorsPerception Capital Corp. IINASDAQ:PCCTWPrenetics GlobalNASDAQ:PRENWQuantum-SiNASDAQ:QSIAWMisonixNASDAQ:MSONKeysight TechnologiesNYSE:KEYSView All CompetitorsInsidersXiaochun XuSold 600,000 sharesTotal: $612,000.00 ($1.02/share)View All Insider Transactions THMO Stock Analysis - Frequently Asked Questions How have THMO shares performed this year? ThermoGenesis' stock was trading at $0.6010 at the start of the year. Since then, THMO stock has decreased by 68.4% and is now trading at $0.19. View the best growth stocks for 2024 here. How were ThermoGenesis' earnings last quarter? ThermoGenesis Holdings, Inc. (NASDAQ:THMO) announced its quarterly earnings results on Friday, May, 17th. The company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.47. The firm earned $2.74 million during the quarter. ThermoGenesis had a negative trailing twelve-month return on equity of 4,838.39% and a negative net margin of 153.43%. When did ThermoGenesis' stock split? ThermoGenesis's stock reverse split on Friday, December 23rd 2022. The 1-45 reverse split was announced on Friday, December 23rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, December 23rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of ThermoGenesis? Shares of THMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of ThermoGenesis own? Based on aggregate information from My MarketBeat watchlists, some other companies that ThermoGenesis investors own include FuelCell Energy (FCEL), Inovio Pharmaceuticals (INO), Co-Diagnostics (CODX), NVIDIA (NVDA), OPKO Health (OPK), Advanced Micro Devices (AMD) and Dynavax Technologies (DVAX). This page (NASDAQ:THMO) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ThermoGenesis Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ThermoGenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.